← Open Payments lookup

MICHELL CADIZ: Open Payments

NPI 1194161554 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,020 in 106 payments from 27 companies in 2025. Trend: 2023 $6,378 · 2024 $2,302 · 2025 $4,020

Food & beverage: $2,550Consulting: $1,470
CompanyPaymentsAmount
Janssen Biotech, Inc.19$1,012
Janssen Pharmaceuticals, Inc1$915
Novartis Pharmaceuticals Corporation19$368
GENZYME CORPORATION9$288
AstraZeneca Pharmaceuticals LP11$239
Takeda Pharmaceuticals U.S.A., Inc.8$183
PFIZER INC.7$166
Janssen Scientific Affairs, LLC1$115
SOBI, INC3$104
Rigel Pharmaceuticals, Inc.3$80

Products named: DARZALEX, Fabhalta, CALQUENCE, TECVAYLI, SARCLISA, RYBREVANT, AYVAKIT, TALVEY.

Industry payments across CA — which companies pay providers there.